Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael MacManus

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 22, 2023
Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 TrialNicholas W Bucknell, Tomas Kron, Alan Herschtal, et al.
British Journal of Cancer|July 21, 2017
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerMarliese Alexander, Rory Wolfe, David Ball, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2014
Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung CancerSarah J Everitt, David L Ball, Rodney J Hicks, et al.
Leukemia & Lymphoma|April 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphomaBelinda A Campbell, Adrian Minson, Rachel J Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancerMing-Yin Lin, Muzo Wu, Sinead Brennan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2008
Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007Michael MacManus, Ursula Nestle, Kenneth E Rosenzweig, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2024
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancerNeil D Wallace, Marliese Alexander, Jing Xie, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLCMichael MacManus, Laura Kirby, Benjamin Blyth, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|April 22, 2023
Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 TrialNicholas W Bucknell, Tomas Kron, Alan Herschtal, et al.
British Journal of Cancer|July 21, 2017
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerMarliese Alexander, Rory Wolfe, David Ball, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2014
Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung CancerSarah J Everitt, David L Ball, Rodney J Hicks, et al.
Leukemia & Lymphoma|April 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphomaBelinda A Campbell, Adrian Minson, Rachel J Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancerMing-Yin Lin, Muzo Wu, Sinead Brennan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2008
Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007Michael MacManus, Ursula Nestle, Kenneth E Rosenzweig, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2024
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancerNeil D Wallace, Marliese Alexander, Jing Xie, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLCMichael MacManus, Laura Kirby, Benjamin Blyth, et al.
Pageof 8